Centene Corporation Reports Strong First Quarter 2026 Results, Raises Full-Year Outlook
Centene Corporation announced solid financial and operational performance for the first quarter of 2026, highlighted by strong earnings, disciplined cost management, and continued progress in improving margins across its core business segments. The company also raised its full-year earnings guidance, reflecting confidence in its growth trajectory and operational execution.
For the quarter ended March 31, 2026, Centene reported GAAP diluted earnings per share (EPS) of $3.11 and adjusted diluted EPS of $3.37, exceeding internal expectations by approximately $0.50. Total revenues reached $49.9 billion, with premium and service revenues contributing $44.7 billion, representing a 5% increase compared to the same period in 2025.
The company’s health benefits ratio (HBR) stood at 87.3%, slightly improved from 87.5% in the prior-year quarter, demonstrating effective cost management and improved pricing strategies. Meanwhile, the selling, general, and administrative (SG&A) expense ratio declined to 7.6%, down from 7.9% a year earlier, reflecting operational efficiencies and disciplined expense control.
Chief Executive Officer Sarah M. London emphasized the company’s progress, noting that Centene continues to strengthen its operational foundation while advancing margin recovery efforts. The strong first-quarter performance has enabled the company to increase its full-year 2026 adjusted EPS guidance to more than $3.40, reinforcing confidence in its long-term earnings potential.
Segment Performance Highlights
Centene’s Medicaid business remained a key contributor, with an HBR of 93.1%, reflecting improved cost management and moderate flu-related expenses. Revenue growth in this segment was supported by rate increases, state-directed payments, and ongoing efforts to address medical cost trends.
The Medicare segment delivered strong results, posting an HBR of 84.9%, driven by outperformance in both Medicare Advantage and Prescription Drug Plan (PDP) offerings. Growth in PDP membership and favorable operational performance contributed significantly to revenue gains in this segment.
In the Commercial segment, the HBR was 75.3%, slightly above expectations due to higher acuity among Marketplace Silver Tier members. Despite this, Marketplace pre-tax earnings remained in line with expectations, supported by favorable SG&A trends and operational discipline.
Revenue and Membership Trends
Premium and service revenues increased to $44.7 billion, up from $42.5 billion in the first quarter of 2025. Medicaid revenues grew by 6%, while Medicare revenues rose sharply by 18%, reflecting strong PDP growth. Commercial revenues declined by 6%, largely due to reduced Marketplace membership.
Total at-risk membership stood at 26.3 million as of March 31, 2026, compared to 27.9 million a year earlier. The decline was primarily driven by lower Marketplace enrollment and shifts in Medicaid membership categories. However, growth in Medicare PDP membership partially offset these declines.
Cash Flow and Balance Sheet Strength
Centene generated strong operating cash flow of $4.4 billion during the quarter, supported by net earnings and favorable timing of payments. The company also demonstrated a commitment to strengthening its balance sheet by reducing debt by $1.0 billion during the quarter.
At the end of March 2026, Centene held $41.8 billion in cash, investments, and restricted deposits, with $437 million available for general corporate use. Total debt stood at $16.4 billion following the repurchase of senior notes due in 2027. The company maintained a solid liquidity position, with no borrowings under its $4.0 billion revolving credit facility.
Medical claims liabilities totaled $20.6 billion, and days in claims payable increased slightly to 48 days, reflecting normal fluctuations in claims processing.
Operational Efficiency and Cost Management
The company’s improved SG&A ratio was driven by multiple factors, including strong cost management, expense leverage from higher revenues, and reduced Marketplace membership, which typically carries higher administrative costs. Additionally, growth in the PDP business, which operates with a lower cost structure, contributed to overall efficiency gains.
Centene’s effective tax rate for the quarter was 26.7%, compared to 24.7% in the prior year. On an adjusted basis, the tax rate was 26.5%.
Community Investment and Social Impact
Beyond financial performance, Centene continued to invest in community-focused initiatives. During the quarter, the company supported affordable housing development in North Carolina, launched a “Food is Medicine” program in Kentucky to assist individuals with diabetes, and funded accessibility improvements for healthcare providers in Ohio.
These initiatives reflect Centene’s broader commitment to addressing social determinants of health and improving access to care for underserved populations.
2026 Outlook and Guidance
Looking ahead, Centene raised its full-year 2026 premium and service revenue guidance to a range of $171.0 billion to $175.0 billion, an increase of $1.0 billion driven primarily by Medicaid growth. The company also increased its investment and other income expectations to $1.45 billion.
The updated earnings outlook includes:
- GAAP diluted EPS of greater than $2.37
- Adjusted diluted EPS of greater than $3.40
For the full year, Centene expects total revenues between $187.5 billion and $191.5 billion. The projected HBR ranges from 90.9% to 91.7%, while the SG&A expense ratio is expected to fall between 7.0% and 7.6%.
The company anticipates an effective tax rate between 27% and 28%, with an adjusted rate between 26% and 27%. Diluted shares outstanding are المتوقع to range from approximately 495.6 million to 498.6 million.
Centene’s first quarter 2026 results demonstrate strong execution across its business segments, supported by effective cost management, solid revenue growth, and strategic focus on high-performing areas such as Medicare PDP. The company’s ability to exceed expectations and raise its full-year guidance underscores confidence in its operational strategy and long-term growth potential.
With continued investments in both business performance and community impact, Centene remains well-positioned to deliver sustainable value for shareholders while improving healthcare access and outcomes for the populations it serves.
About Centene Corporation
Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach with local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.
Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors
